Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant driver of that…

Continue Reading

News Source: medicalxpress.com